Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,105 | 454 | 405 | 470 | 1,546 |
| Marketable Securities | 25 | N/A | N/A | N/A | N/A |
| Receivables | 41 | 87 | 34 | 49 | 44 |
| Inventories | 658 | 1,349 | 1,360 | 1,433 | 1,510 |
| Other current assets | 175 | 263 | 1,097 | 1,099 | 1,150 |
| TOTAL | $2,004 | $2,153 | $2,896 | $3,051 | $4,250 |
| Non-Current Assets | |||||
| PPE Net | 2,175 | 3,097 | 3,220 | 3,348 | 3,468 |
| Intangibles | 4,879 | 1,997 | 1,852 | 1,869 | 1,803 |
| Other Non-Current Assets | 685 | 696 | 779 | 810 | 848 |
| TOTAL | $7,739 | $5,790 | $5,851 | $6,027 | $6,119 |
| Total Assets | $9,743 | $7,943 | $8,747 | $9,078 | $10,369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 628 | 933 | 883 | 835 | 768 |
| Accrued Expenses | 886 | 792 | 1,374 | 1,822 | 2,034 |
| TOTAL | $1,514 | $1,725 | $2,257 | $2,657 | $2,802 |
| Non-Current Liabilities | |||||
| Long Term Debt | 132 | 133 | 134 | 134 | 135 |
| Other Non-Current Liabilities | 5 | 7 | 26 | 28 | 55 |
| TOTAL | $137 | $140 | $160 | $162 | $190 |
| Total Liabilities | $1,651 | $1,865 | $2,417 | $2,819 | $2,992 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,868 | 90,809 | 83,892 | 79,685 | 77,449 |
| Common Shares | 135,774 | 131,920 | 130,570 | 129,307 | 128,578 |
| Retained earnings | -122,828 | -122,343 | -120,744 | -119,589 | -117,760 |
| Other shareholders' equity | -4,854 | -3,499 | -3,496 | -3,459 | -3,441 |
| TOTAL | $8,092 | $6,078 | $6,330 | $6,259 | $7,377 |
| Total Liabilities And Equity | $9,743 | $7,943 | $8,747 | $9,078 | $10,369 |